News from Zyme and the companies we work with.
FairJourney Biologics announces THE ANTIBODY SERIES 2022
Success of the first conference inspires demand for bigger 2022 conference Ton Logtenberg officially announced as Chairman of the 2022 Series Porto, Portugal – 16 September 2021: FairJourney Biologics S.A., [...]
Owlstone Medical Appoints Mark Capone to Board of Directors
Appointment will strengthen leadership team for Breath Biopsy deployment in clinic Cambridge, UK, 16 September 2021: Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection [...]
GammaDelta Therapeutics Initiates First-in-Human Phase 1 Trial of GDX012 for the Treatment of Acute Myeloid Leukaemia
First dose delivered to patients in a multi-centre U.S. clinical trial to evaluate novel gamma-delta T cell cancer therapy London, UK, 15 Sept 2021: GammaDelta Therapeutics Ltd. (GDT), a biotechnology [...]
Insightful Science Acquires FCS Express, Strengthening its Leadership Position as The Cloud for Scientific Discovery
FCS Express expands the flow cytometry solutions within the Insightful Science platform, enabling world-class data-driven scientific research in academia and biopharma and clinical analysis in regulated enterprise environments. Insightful Science [...]
Optibrium Releases 3D Ligand-based Design Module for StarDrop Drug Discovery Software
Innovative predictive methods support virtual screening and compound design in the absence of 3D structure data CAMBRIDGE, UK, 09 September 2021: Optibrium Ltd, a developer of software for drug discovery, [...]
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Round led by Horizons Ventures, joined by new high-profile global investors Investment will fund further platform development, and advancement and commercialization of proprietary tests in lung cancer, liver disease, respiratory [...]
Avacta announces new appointments to the Scientific Advisory Board of its Therapeutics Division
Cambridge and Wetherby, UK, 6 September 2021: Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and [...]
Avacta appoints Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division
Cambridge and Wetherby, UK, 02 September 2021: Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and [...]
FairJourney Biologics expands into new facilities in Porto, Portugal
Newly purpose-built research center supports rapid expansion of Company Porto, Portugal– 01 September 2021: FairJourney Biologics S.A. (FJB), leader in the discovery and optimization of antibodies, today announced it has [...]
Dotmatics Appoints Michael Swartz as Senior Vice President Enterprise Product to Support Continued Rapid Growth
Industry leader from PerkinElmer joins the Dotmatics and Insightful Science team to lead enterprise product vision, strategy, and roadmap Bishop’s Stortford, UK and San Diego, CA, 24th August 2021 — [...]
Avacta appoints Dr. Mark Goldberg as Non-Executive Director
Cambridge and Wetherby, UK, 19 August 2021: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ [...]
ELRIG UK Announces Drug Discovery 2021 Event to Host SLAS’s Innovation AveNEW
ELRIG Drug Discovery 2021, ACC Liverpool, UK, 19–20 October Face-to-face event aims to re-connect, re-invent, and re-imagine drug discovery SLAS’s Innovation AveNEW promotes start-ups by awarding free-of-charge exhibition space and [...]
